Nuvation Bio Inc - Ordinary Shares - Class A

NYSE:NUVB   3:59:57 PM EDT
5.67
-0.04 (-0.70%)
Products

Nuvation Bio Receives FDA Fast Track Designation For NUV-422 For The Treatment Of High-Grade Gliomas, Including Glioblastoma Multiforme

Published: 12/15/2021 14:23 GMT
Nuvation Bio Inc - Ordinary Shares - Class A (NUVB) - Nuvation Bio Receives FDA Fast Track Designation for Nuv-422 for the Treatment of High-grade Gliomas, Including Glioblastoma Multiforme.